Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Akero Therapeutics, Inc. (AKRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Akero Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Avidity Partners Management LP reports a 8.2% stake in Akero Therapeutics, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
SC 13G/A
| GOLDMAN SACHS GROUP INC reports a 1% stake in AKERO THERAPEUTICS, INC |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/05/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.6% stake in Akero Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 5% stake in Akero Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Atlas Venture Fund XI, L.P. reports a 5.6% stake in Akero Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| JANUS HENDERSON GROUP PLC reports a 9.1% stake in Akero Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/10/2020 |
SC 13G/A
| HENDERSON GROUP PLC reports a 10.1% stake in Akero Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|